NEWAMSTERDAM PHARMA CO NV (NAMS) Stock Analyst Ratings
NASDAQ:NAMS - NL00150012L7 - Common Stock
27 USD
+1.34 (+5.22%)
27 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 86% to NAMS. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 42.38. This target is 56.95% above the current price.
NAMS was analyzed by 20 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about NAMS.
In the previous month the buy percentage consensus was at a similar level.
NAMS was analyzed by 20 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-08-25 | Wells Fargo | Initiate | Overweight |
| 2025-08-07 | RBC Capital | Maintains | Outperform -> Outperform |
| 2025-07-17 | Goldman Sachs | Initiate | Neutral |
| 2025-06-17 | Citigroup | Initiate | Buy |
| 2025-06-12 | Needham | Reiterate | Buy -> Buy |
| 2025-06-10 | Stifel | Initiate | Buy |
| 2025-05-08 | Needham | Maintains | Buy -> Buy |
| 2025-04-08 | Needham | Reiterate | Buy -> Buy |
| 2025-02-27 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2025-02-27 | Needham | Maintains | Buy -> Buy |
| 2025-01-28 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-24 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2025-01-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-12-30 | HC Wainwright & Co. | Initiate | Buy |
| 2024-12-11 | ScotiaBank | Maintains | Sector Outperform -> Sector Outperform |
| 2024-12-05 | Needham | Reiterate | Buy -> Buy |
| 2024-11-21 | Needham | Reiterate | Buy -> Buy |
| 2024-11-11 | Needham | Reiterate | Buy -> Buy |
| 2024-11-07 | Needham | Reiterate | Buy -> Buy |
| 2024-09-23 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-09-05 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-08-28 | Needham | Initiate | Buy |
| 2024-07-30 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-06-07 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2024-05-15 | TD Cowen | Initiate | Buy |
| 2024-03-14 | ScotiaBank | Initiate | Sector Outperform -> Sector Outperform |
| 2024-03-13 | ScotiaBank | Initiate | Sector Outperform |
| 2024-02-29 | RBC Capital | Maintains | Outperform -> Outperform |
| 2024-01-18 | Guggenheim | Initiate | Buy |
| 2024-01-16 | Piper Sandler | Initiate | Overweight |